Research Topics
Genomes and GenesSpecies | Ruud van WinkelSummaryAffiliation: Katholieke Universiteit Leuven Country: Belgium Publications
| Collaborators
|
Detail Information
Publications
Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorderRuud van Winkel
University Psychiatric Center, Katholieke Universiteit Leuven, Kortenberg, Belgium
J Clin Psychiatry 69:472-9. 2008..To investigate 3-month changes in glucose metabolism in a naturalistic sample of patients with schizophrenia newly started on or switched to specific atypical antipsychotic medication therapy...
Evidence that the COMTVal158Met polymorphism moderates subclinical psychotic and affective symptoms in unaffected first-degree relatives of patients with schizophreniaRuud van Winkel
University Psychiatric Center, Katholieke Universiteit Leuven, Leuvensesteenweg 517, 3070 Kortenberg, Belgium
Eur Psychiatry 23:219-22. 2008....
Psychiatric diagnosis as an independent risk factor for metabolic disturbances: results from a comprehensive, naturalistic screening programRuud van Winkel
University Psychiatric Center Catholic University Leuven, Kortenberg, Belgium
J Clin Psychiatry 69:1319-27. 2008..Unconfounded differences in inherent vulnerability to metabolic disturbance may be hypothesized for different diagnostic groups with severe mental illness...
Premorbid IQ as a predictor for the course of IQ in first onset patients with schizophrenia: a 10-year follow-up studyRuud van Winkel
University Psychiatric Center Katholieke Universiteit Leuven, Leuvensesteenweg 517, 3070 Kortenberg, Belgium
Schizophr Res 88:47-54. 2006..Rather, catching up of cognitive function later in the course of the illness may take place in those whose deficits become apparent in the early phases of illness, whereas those with the most severe premorbid impairments remain stable...
Screening for diabetes and other metabolic abnormalities in patients with schizophrenia and schizoaffective disorder: evaluation of incidence and screening methodsRuud van Winkel
University Psychiatric Center, Katholieke Universiteit Leuven, Kortenberg, Belgium
J Clin Psychiatry 67:1493-500. 2006..The alternative 2-step strategy was able to detect the vast majority of diabetes cases and should therefore be considered in the clinical routine of screening and monitoring patients with schizophrenia...
A case series: evaluation of the metabolic safety of aripiprazoleMarc De Hert
University Psychiatric Center Katholieke Universiteit Leuven, Leuvense Steenweg 517, 3070 Kortenberg, Belgium
Schizophr Bull 33:823-30. 2007..The MetS was reversed in 50% of patients at 3 months follow-up. Our results support the reversibility of recent onset diabetes on antipsychotic medication when detected early and followed by a switch to aripiprazole...
Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorderRuud van Winkel
University Psychiatric Center Katholieke Universiteit Leuven, Kortenberg, Belgium
Bipolar Disord 10:342-8. 2008..There are limited data on the prevalence of the metabolic abnormalities in disorders other than schizophrenia in which antipsychotic medication is part of routine treatment...
Evidence that the COMT(Val158Met) polymorphism moderates sensitivity to stress in psychosis: an experience-sampling studyRuud van Winkel
University Psychiatric Center Katholieke Universiteit Leuven, Leuvensesteenweg, Kortenberg, Belgium
Am J Med Genet B Neuropsychiatr Genet 147:10-7. 2008....
Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysisMarc De Hert
University Psychiatric Centre, Catholic University Leuven, Kortenberg, Belgium
CNS Drugs 26:733-59. 2012..However, until now, the metabolic risk profile of the newly approved SGAs - asenapine, iloperidone, lurasidone and paliperidone (paliperidone extended release and paliperidone palmitate) - has not been compared...
Treatment with rosuvastatin for severe dyslipidemia in patients with schizophrenia and schizoaffective disorderMarc De Hert
University Psychiatric Center, Katholieke Universiteit Leuven, Kortenberg, Belgium
J Clin Psychiatry 67:1889-96. 2006..Use of lipid-lowering drugs such as statins is recommended when lifestyle changes are not sufficient to reach the LDL goal. The efficacy and safety of rosuvastatin treatment were evaluated in schizophrenic patients...
Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label studyMartien Wampers
University Psychiatric Centre Catholic University Leuven, campus Kortenberg, Kortenberg, Belgium
Eur Neuropsychopharmacol 22:17-26. 2012..The observed olanzapine-associated reduction in plasma adiponectin levels may at least partially contribute to the increased metabolic risk of olanzapine compared to risperidone...
Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart reviewMarc De Hert
University Psychiatric Center Katholieke Universiteit Leuven, Leuvense Steenweg 517, 3070 Kortenberg, Belgium
Schizophr Res 101:295-303. 2008..There are limited data on the prevalence of MetS in patients with schizophrenia at the onset of the disorder and specifically no data on patients treated in the era when only first-generation antipsychotics were available...
Effects of cannabis use on age at onset in schizophrenia and bipolar disorderMarc De Hert
University Psychiatric Centre Catholic University Leuven campus Kortenberg, Leuvense Steenweg 517, 3070 Kortenberg, Belgium
Schizophr Res 126:270-6. 2011..Cannabis use may decrease age at onset in both schizophrenia and bipolar disorder, given the evidence for substantial phenotypic and genetic overlap between both disorders...
Remission criteria for schizophrenia: evaluation in a large naturalistic cohortMarc De Hert
University Psychiatric Centre Catholic University Louvain, Leuvensesteenweg 517, 3070 Kortenberg, Belgium
Schizophr Res 92:68-73. 2007..Little is known, however, about the added value of the time criterion in addition to the cross-sectional severity criterion...
Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medicationMarc A De Hert
University Center St Jozef, Catholic University Louvain, Leuvense Steenweg 517, 3070 Kortenberg, Belgium
Schizophr Res 83:87-93. 2006..The presence of the metabolic syndrome is an important risk factor for cardiovascular disease and diabetes. There are limited data on the prevalence of the metabolic syndrome in European patients suffering from schizophrenia...
Body weight and self-esteem in patients with schizophrenia evaluated with B-WISEMarc De Hert
University Psychiatric Center Katholieke Universiteit Leuven, Leuvense Steenweg 517, 3070 Kortenberg, Belgium
Schizophr Res 88:222-6. 2006..The second objective was to explore the association of B-WISE scores with the metabolic syndrome and glucose abnormalities...
Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophreniaDavy Vancampfort
University Psychiatric Center, Catholic University Leuven, campus Kortenberg, Belgium
Psychiatry Res 177:271-9. 2010..More research is needed to assist in the practical development of effective evidence-based preventive and curative strategies in psychiatric services for metabolic syndrome in persons with schizophrenia...
Age at onset of psychotic disorder: cannabis, BDNF Val66Met, and sex-specific models of gene-environment interactionJeroen Decoster
University Psychiatric Centre Catholic University Leuven, Kortenberg, Belgium
Am J Med Genet B Neuropsychiatr Genet 156:363-9. 2011..No compelling evidence was found that BDNF genotype is associated with age at onset of psychotic disorder in the absence of cannabis use...
Anticholinergic use in hospitalised schizophrenic patients in BelgiumMarc De Hert
University Psychiatric Centre Katholieke Universiteit Leuven, campus Kortenberg, Leuvensesteenweg 517, 3070 Kortenberg, Belgium
Psychiatry Res 152:165-72. 2007..However, there were no significant differences in the prevalence of EPS with the exception of akathisia between FGA and SGA. Thus, through the use of anticholinergics, EPS induced by FGA can be effectively reduced...
Metabolic and cardiovascular adverse effects associated with antipsychotic drugsMarc De Hert
University Psychiatric Center, Catholic University Leuven, Leuvensesteenweg 517, 3070 Kortenberg, Belgium marc de hert uc kortenberg be
Nat Rev Endocrinol 8:114-26. 2012....
Incident somatic comorbidity after psychosis: results from a retrospective cohort study based on Flemish general practice dataCarla Truyers
Department of General Practice, Katholieke Universiteit Leuven, Leuven, Belgium
BMC Fam Pract 12:132. 2011..Many studies are performed in specialized settings with a strong focus on schizophrenia. Somatic comorbidity after psychosis is studied, using a general practice comorbidity registration network...
Childhood trauma as a cause of psychosis: linking genes, psychology, and biologyRuud van Winkel
Department of Psychiatry and Psychology, School for Mental Health and Neuroscience, European Graduate School of Neuroscience, EURON, Maastricht University Medical Centre, Maastricht, The Netherlands
Can J Psychiatry 58:44-51. 2013....
Metabolic syndrome in people with schizophrenia: a reviewMarc De Hert
University Psychiatric Center, Catholic University Leuven, Leuvensesteenweg 517, 3070 Kortenberg, Belgium
World Psychiatry 8:15-22. 2009..The somatic treatments offered to people with severe and enduring mental illness should be at par with general health care in the non-psychiatrically ill population...
Pharmacological treatment of severe dyslipidaemia in patients with schizophreniaLinda Hanssens
Department of Epidemiology and Public Health, Nutrition and Metabolic Disorders CHU Sart Tilman, University Liege, Liege, Belgium
Int Clin Psychopharmacol 22:43-9. 2007..Statins proved effective in the management of dyslipidaemia in patients with schizophrenia treated with antipsychotics. More complex treatment may be required for associated metabolic disturbances...
Reversibility of antipsychotic treatment-related diabetes in patients with schizophrenia: a case series of switching to aripiprazoleMarc De Hert
Diabetes Care 29:2329-30. 2006
Clinical trials and tribulations: perspectives on research career developmentMarlene P Freeman
J Clin Psychiatry 69:470-1. 2008
